Changes to This Summary (09/19/2014)
Added text to state that in April 2014, the U.S. Food and Drug Administration approved a Human Papillomavirus DNS test that can be used alone for the primary screening of cervical cancer in women aged 25 years and older (cited the U. S. Food and Drug Administration as reference 4).
This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.